HUNTSVILLE, AL — September 8, 2025 — Leads & Copy — Serina Therapeutics, Inc. (NYSE American: SER) announced that CEO Steve Ledger will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York, NY, today at 9:30 a.m. ET.
A live webcast will be available to registered attendees, with an archived replay on-demand for 90 days following the event.
Serina is a clinical-stage biotechnology company developing drug product candidates for neurological diseases, utilizing its POZ Platform™ to improve the efficacy and safety of small molecules, RNA-based therapeutics, and antibody-based drug conjugates (ADCs). The company is headquartered in Huntsville, Alabama, on the campus of the HudsonAlpha Institute of Biotechnology.
Stefan Riley
sriley@serinatherapeutics.com
(256) 327-9630
Source: Serina Therapeutics, Inc.
